Brokerages predict that Henry Schein, Inc. (NASDAQ:HSIC) will announce sales of $3.04 billion for the current fiscal quarter, according to Zacks. Nine analysts have made estimates for Henry Schein’s earnings, with estimates ranging from $3.00 billion to $3.11 billion. Henry Schein posted sales of $2.87 billion during the same quarter last year, which suggests a positive year-over-year growth rate of 5.9%. The firm is expected to report its next quarterly earnings results on Thursday, August 3rd.

According to Zacks, analysts expect that Henry Schein will report full-year sales of $3.04 billion for the current financial year, with estimates ranging from $12.11 billion to $12.34 billion. For the next year, analysts anticipate that the business will post sales of $12.89 billion per share, with estimates ranging from $12.75 billion to $13.08 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research firms that that provide coverage for Henry Schein.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, May 9th. The company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.65 by $0.11. Henry Schein had a return on equity of 19.74% and a net margin of 4.53%. The company had revenue of $2.92 billion for the quarter, compared to analysts’ expectations of $2.83 billion. During the same period last year, the firm earned $1.41 EPS. The firm’s revenue for the quarter was up 7.7% on a year-over-year basis.

Several analysts have commented on HSIC shares. Stifel Nicolaus upped their target price on shares of Henry Schein from $174.00 to $178.00 and gave the company a “hold” rating in a research report on Wednesday, May 10th. Zacks Investment Research upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $204.00 target price for the company in a research report on Thursday, May 25th. Piper Jaffray Companies started coverage on shares of Henry Schein in a research report on Monday, June 12th. They set a “neutral” rating and a $200.00 target price for the company. Craig Hallum started coverage on shares of Henry Schein in a research report on Tuesday, April 11th. They set a “hold” rating for the company. Finally, Credit Suisse Group reiterated a “hold” rating and set a $160.00 target price on shares of Henry Schein in a research report on Thursday. Eleven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Henry Schein presently has an average rating of “Hold” and an average target price of $182.36.

Henry Schein (NASDAQ:HSIC) opened at 184.52 on Friday. Henry Schein has a 12 month low of $146.23 and a 12 month high of $186.99. The stock’s 50 day moving average price is $182.32 and its 200 day moving average price is $169.72. The firm has a market capitalization of $14.64 billion, a PE ratio of 28.04 and a beta of 1.09.

ILLEGAL ACTIVITY NOTICE: This report was first posted by American Banking News and is owned by of American Banking News. If you are accessing this report on another website, it was stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this report can be accessed at https://www.americanbankingnews.com/2017/07/15/3-04-billion-in-sales-expected-for-henry-schein-inc-nasdaqhsic-this-quarter.html.

In other news, EVP Gerald A. Benjamin sold 12,578 shares of the stock in a transaction dated Thursday, May 11th. The shares were sold at an average price of $175.10, for a total transaction of $2,202,407.80. Following the completion of the transaction, the executive vice president now directly owns 44,061 shares in the company, valued at approximately $7,715,081.10. The transaction was disclosed in a document filed with the SEC, which is available at this link. 1.27% of the stock is currently owned by corporate insiders.

Several institutional investors have recently bought and sold shares of the company. SpiderRock Advisors LLC acquired a new position in Henry Schein during the first quarter worth approximately $102,000. JNBA Financial Advisors acquired a new position in Henry Schein during the first quarter worth approximately $170,000. Westside Investment Management Inc. purchased a new stake in shares of Henry Schein during the first quarter valued at about $168,000. Peddock Capital Advisors LLC increased its stake in shares of Henry Schein by 29.1% in the first quarter. Peddock Capital Advisors LLC now owns 1,097 shares of the company’s stock valued at $186,000 after buying an additional 247 shares during the period. Finally, Van ECK Associates Corp increased its stake in shares of Henry Schein by 5.7% in the first quarter. Van ECK Associates Corp now owns 1,138 shares of the company’s stock valued at $193,000 after buying an additional 61 shares during the period. Institutional investors own 90.73% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Get a free copy of the Zacks research report on Henry Schein (HSIC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.